Overview Melanoma is a unique type of skin cancer that originates from cells known as melanocytes. The main function of these cells is to produce a substance called melanin, which…
Background: The approval of Libtayo (Cemiplimab-rwlc) by the FDA has marked the start of a new drug protocol that can help lung cancer patients. This is a huge breakthrough in…
Straight to the Point in Triple Negative Breast Cancer Leronlimab (PRO 140) has demonstrated promising preliminary results in a phase 1b/2 clinical trial (NCT03838367) for patients with metastatic triple negative…
Overview Doctors often struggle with treating advanced stages of breast cancer, especially Triple Negative Breast Cancer, TNBC. When the tumor is located in a confined area, it is relatively easier…
The treatment that is given "according to the book" to everyone, is called in professional language "the standard protocol". LB, our client, 62, was diagnosed with stage 4 cancer three…
Background Despite the advances and strides that modern medicine has made, prostate cancer treatment options remain to be fairly reserved. However, the day is finally here that more methods of…
Overview - Breast cancer and [vic-]trastuzumab duocarmazine (SYD985) and In a recent press release by Byondis, the pharmaceutical company expressed excitement and optimism about the clinical results of their new…
Background The utilization of FMT can influence how metastatic melanoma patients respond to anti-PD-1 immunotherapy. Numerous microbes inhabit the human gut. The colon itself has approximately 1000 different species of…
Background - New option for Liver cancer Hepatic Arterial Infusion Chemotherapy, HAIC, is a medical procedure that delivers chemotherapy directly to the liver and widely used. Toripalimab an antibody against…
Background The first findings of KEYNOTE-811, an ongoing, global phase III trial, found that the addition of Keytruda to Herceptin plus chemotherapy for first-line treatment in patients with HER2-positive unresectable…